Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Accounts Payables (2020 - 2024)

RAPT Therapeutics' Accounts Payables history spans 5 years, with the latest figure at $1.4 million for Q3 2024.

  • For Q3 2024, Accounts Payables fell 73.95% year-over-year to $1.4 million; the TTM value through Sep 2024 reached $1.4 million, down 73.95%, while the annual FY2023 figure was $5.2 million, 53.82% up from the prior year.
  • Accounts Payables for Q3 2024 was $1.4 million at RAPT Therapeutics, down from $2.7 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $8.9 million in Q1 2023 and bottomed at $1.4 million in Q3 2024.
  • The 5-year median for Accounts Payables is $3.4 million (2022), against an average of $3.7 million.
  • The largest annual shift saw Accounts Payables surged 361.83% in 2023 before it crashed 73.95% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $2.4 million in 2020, then fell by 16.11% to $2.0 million in 2021, then soared by 68.33% to $3.4 million in 2022, then soared by 53.82% to $5.2 million in 2023, then crashed by 73.34% to $1.4 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Accounts Payables are $1.4 million (Q3 2024), $2.7 million (Q2 2024), and $6.8 million (Q1 2024).